This is an invitation to contribute your voice into the development of World Health Organization Guidelines on the use of digital tools for reproductive, maternal, child, and adolescent health outcomes. Please note that we ask that you submit your responses to this first iteration of feedback by Monday, 26 September 2016. This survey will take approximately 30 minutes, and your inputs will provide valuable insights in shaping the development of this critical resource to WHO member states and other stakeholders.
Link to the survey: https://www.surveymonkey.com/r/ZRYWKWH
Over the past few months, the World Health Organization’s Department of Reproductive Health (RHR) and Research has embarked on developing Guidelines featuring evidence-based recommendations on the use of digital strategies to improve reproductive, maternal, newborn, child, and adolescent health (RMNCAH), as well as accountability mechanisms. This guideline development comes as an explicit response to requests from WHO member states on guidance on identifying which digital health strategies are evidence-based and offer comparative value for strengthening health systems and addressing RMNCAH needs. Recommendations emerging from this Guideline are intended to support the objectives of the Global Strategy for Women’s, Children’s and Adolescents’ Health, and serve as a resource to the Health Data Collaborative.
As part of the Guideline development process, key research questions have been drafted as areas for further examination on the evidence supporting the use of digital strategies for RMNCAH. These questions will be refined through a consultative process with an WHO advisory group. However, we also would like to provide an opportunity for individuals across government, implementer, donor, and academic stakeholder groups to prioritize questions that should be addressed in the upcoming Guideline.
In order to inform the WHO RHR Secretariat and the Guideline advisory group, we ask that you complete this survey on prioritization the questions and outcomes for inclusion in the Guideline.
Thank you in advance for your valuable contributions.
Dr Garrett Mehl
Garrett Mehl, PhD, MHS
Scientist, Digital Innovations
Department of Reproductive Health and Research, includes
HRP - the UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research in Human Reproduction
World Health Organization
20 Avenue Appia
Link leads to: https://www.surveymonkey.com/r/ZRYWKWH